Echo Therapeutics (ECTE) Underwriters Exercise Full Overallotment in 3.2M Offering

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the full exercise of the over-allotment option granted to the underwriters to purchase 480,000 additional common shares, at a public offering price of $0.95 per share, in connection with its previously announced underwritten public offering of 3,200,000 shares of common stock, bringing the total gross proceeds from the offering to $3,496,000, before deducting the underwriting discount and other offering expenses payable by Echo.

Aegis Capital Corp. acted as the sole book-running manager for the offering.

Feltl and Company acted as co-manager for the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Mangoceuticals (MGRX) Files for 30.01M Share Offering by Selling Stockholders
• Centessa Pharmaceuticals (CNTA) Announces $100 Million Proposed Public Offering of American Depositary Shares
• Lipocine (LPCN) Files $150M Mixed Shelf